[1]
Éckeli, F.D. 2020. Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans. Headache Medicine. 11, 3 (Sep. 2020), 78. DOI:https://doi.org/10.48208/HeadacheMed.2020.22.